GlassScriptPhysician profile
Charles Chaboude
NPI 1437679628
$12,076.64
in general payments reported to CMS, 2019-2025
52 companies · $3,236 in 2025
The $3,236 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $751 · 2022: $2,076 · 2023: $2,929 · 2024: $3,086 · 2025: $3,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,249.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,637.24 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $1,467.44 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,203.28 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Sanofi-Aventis U.S. LLC | $788.03 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $767.68 | 2022-2025 | |
| Dexcom, INC. | $702.10 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Abbvie INC. | $528.76 | 2021-2025 | |
| Amgen INC. | $383.44 | 2024-2025 | Evenity, Repatha, Prolia |
| Novartis Pharmaceuticals Corporation | $382.24 | 2022-2025 | |
| Abbott Laboratories | $285.16 | 2022-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $284.15 | 2022-2025 | Afrezza |
| Pfizer INC. | $278.60 | 2021-2024 | |
| Xeris Pharmaceuticals, INC. | $251.69 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Recordati_rare_diseases_inc. | $238.43 | 2022-2025 | Isturisa, Signifor Lar |
| Tandem Diabetes Care, INC. | $218.15 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $207.15 | 2023-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Amneal Pharmaceuticals LLC | $200.02 | 2022-2025 | Unithroid |
| Corcept Therapeutics | $191.40 | 2023-2025 | Korlym |
| Beta Bionics, INC. | $191.19 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Endo Pharmaceuticals INC. | $174.58 | 2022-2024 | Aveed |
| Antares Pharma, INC. | $168.91 | 2022-2025 | Xyosted |
| Insulet Corporation | $145.68 | 2024 | Omnipod |
| Horizon Therapeutics Plc | $118.75 | 2022 | |
| Neurocrine Biosciences, INC. | $117.53 | 2025 | |
| Sequel Med Tech, LLC | $94.75 | 2025 | Twiist |
| Madrigal Pharmaceuticals | $88.57 | 2025 | Rezdiffra |
| Alexion Pharmaceuticals, INC. | $88.20 | 2022-2025 | Strensiq |
| Kyowa Kirin, INC. | $87.23 | 2023-2024 | Crysvita |
| Ascendis Pharma Endocrinology INC | $73.62 | 2025 | Yorvipath |
| Acella Pharmaceuticals, LLC | $63.45 | 2022-2025 | NP Thyroid 60 |
| Endo USA, INC. | $58.68 | 2024-2025 | Aveed |
| Eusa Pharma (US) LLC | $55.83 | 2022 | |
| Lifescan, INC. | $48.55 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $40.77 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $40.25 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.06 | 2023 | Cycloset |
| Esperion Therapeutics, INC. | $34.81 | 2021 | |
| Boston Scientific Corporation | $31.40 | 2025 | General - Pain Management |
| Rhythm Pharmaceuticals, INC. | $30.89 | 2025 | Imcivree |
| Verity Pharmaceuticals INC. | $28.60 | 2025 | Tlando |
| Eisai INC. | $25.01 | 2025 | |
| Glaxosmithkline, LLC. | $24.73 | 2021 | |
| Nevro Corp. | $22.09 | 2022 | |
| Ibsa Pharma INC. | $21.48 | 2025 | Flector, Licart, Tirosint |
| Avvisto Therapeutics, LLC | $20.99 | 2025 | Cycloset |
| Radius Health, INC. | $19.82 | 2024 | Tymlos |
| Zealand Pharma US, INC. | $19.69 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.12 | 2021 | |
| Halozyme INC | $18.80 | 2023 | |
| Cequr Corporation | $18.64 | 2025 | Cequr Simplicity |
| Arbor Pharmaceuticals, INC. | $17.13 | 2021 | |
| Azurity Pharmaceuticals, INC. | $15.88 | 2023 | Adthyza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Chaboude listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.